Z-1312-2021 Class II Terminated

Recalled by LumiraDx — Waltham, MA

FDA device recall Z-1312-2021 was initiated by LumiraDx on Feb 3, 2021 and is designated Class II. Reason for recall: Two lots of test strips failed QC testing using blank buffer due to false positives. The recall status is terminated (terminated Jul 13, 2022). Affected quantity: 2186 devices.

Recall details

Product Type
Devices
Report Date
Apr 7, 2021
Initiation Date
Feb 3, 2021
Termination Date
Jul 13, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2186 devices

Product description

Coronavirus antigen detection test system - Product Usage: intended for the qualitative detection of the nucleocapsid protein antigen to SARS-CoV-2 directly from nasal swab samples collected from individuals suspected of COVID-19 by their healthcare provider within the first twelve days of symptom onset.

Reason for recall

Two lots of test strips failed QC testing using blank buffer due to false positives.

Distribution pattern

US nationwide distribution.

Code information

catalog #: L001000330001

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1312-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1312-2021. Report a data issue: hello@regdatalab.com.